Elfatih Elzein

1.0k citations

28 papers · 849 indexed · h-index 20

Molecular Biology
Physiology top 0.5%
Organic Chemistry top 10%
Cardiology and Cardiovascular Medicine top 10%
Cellular and Molecular Neuroscience

Co-authors: Jeff Zablocki Venkata P. Palle Rao Kalla Dewan Zeng William F. Kiesman Thao Perry Aleem Gangjee Xiaofen Li
Topics: Adenosine and Purinergic Signaling (14 papers)Synthesis and Biological Evaluation (9 papers)Cardiac electrophysiology and arrhythmias (5 papers)
Cited by: Physiology Organic Chemistry Cardiology and Cardiovascular Medicine
Journals: Journal of Clinical Oncology Cancer Research Journal of Medicinal Chemistry
Partner nations: United States Belarus United Kingdom

In The Last Decade

Elfatih Elzein

28 papers receiving 824 citations

Peers

Countries citing papers authored by Elfatih Elzein

Since Specialization

Citations

This map shows the geographic impact of Elfatih Elzein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elfatih Elzein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elfatih Elzein more than expected).

Fields of papers citing papers by Elfatih Elzein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elfatih Elzein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elfatih Elzein. The network helps show where Elfatih Elzein may publish in the future.

Co-authorship network of co-authors of Elfatih Elzein

This figure shows the co-authorship network connecting the top 25 collaborators of Elfatih Elzein. A scholar is included among the top collaborators of Elfatih Elzein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elfatih Elzein. Elfatih Elzein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of TT-816, a novel immune response modifier targeting cannabinoid CB₂ receptor, on antitumor immunity and cancer growth. 2024 ·Journal of Clinical Oncology ·Peidong Fan,Elfatih Elzein,Lina Yao	1
2	Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII) 2017 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun,(unknown),Rao Kalla,Thao Perry,Elfatih Elzein,Xiaofen Li,Scott P. Simonovich,(unknown),Timothy R. Hansen,Bruno Marchand,(unknown),Leanna Lagpacan,Magdeleine Hung,(unknown),Bernard P. Murray,Jason K. Perry,John R. Somoza,Armando G. Villaseñor,Nikos Pagratis,Jeff Zablocki	5
3	Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine 2016 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun,(unknown),Elfatih Elzein,Tetsuya Kobayashi,(unknown),Xiaofen Li,Thao Perry,(unknown),Weiqun Wang,Ryoko Hirakawa,Catherine J. Smith‐Maxwell,Lin Wu,Arvinder K. Dhalla,Sridharan Rajamani,Névéna Mollova,(unknown),Jennifer Tang,Luiz Belardinelli,Jeff Zablocki	27
4	The novel late Na⁺ current inhibitor, GS‐6615 (eleclazine) and its anti‐arrhythmic effects in rabbit isolated heart preparations 2016 ·British Journal of Pharmacology ·Sridharan Rajamani,(unknown),Nesrine El‐Bizri,Donglin Guo,(unknown),(unknown),Kristopher M. Kahlig,Névéna Mollova,Elfatih Elzein,Jeff Zablocki,Luiz Belardinelli	28
5	A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers 2009 ·Handbook of experimental pharmacology ·William F. Kiesman,Elfatih Elzein,Jeff Zablocki	77
6	A₁adenosine receptor agonists and their potential therapeutic applications 2008 ·Expert Opinion on Investigational Drugs ·Elfatih Elzein,Jeff Zablocki	73
7	Selective, high affinity A2B adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines 2008 ·Bioorganic & Medicinal Chemistry Letters ·Rao Kalla,Elfatih Elzein,Thao Perry,Xiaofen Li,(unknown),Ming Yang,Dewan Zeng,Jeff Zablocki	33
8	N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein,Rao Kalla,Xiaofen Li,Thao Perry,(unknown),(unknown),(unknown),Yuzhi Wu,Dewan Zeng,Jeff Zablocki	24
9	Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein,Rao Kalla,Xiaofen Li,Thao Perry,(unknown),Venkata P. Palle,(unknown),(unknown),Dewan Zeng,(unknown),Kwan Leung,Jeff Zablocki	37
10	Novel inhibitors of fatty acid oxidation as potential metabolic modulators 2004 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein,Kevin D. Shenk,Prabha N. Ibrahim,(unknown),S.S. Kerwar,Stephanie Meyer,(unknown),Dewan Zeng,Nancy Chu,(unknown),Shirley M.E. Wong,Kwan Leung,Jeff Zablocki	6
11	Structure–affinity relationships of 5′-aromatic ethers and 5′-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Elfatih Elzein,(unknown),Prabha N. Ibrahim,(unknown),Venkata P. Palle,Kevin D. Shenk,(unknown),(unknown),(unknown),Yuzhi Wu,Dewan Zeng,(unknown),(unknown),Kwan Leung,Jeff Zablocki	16
12	CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability 2004 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein,Prabha N. Ibrahim,Dmitry O. Koltun,(unknown),Kevin D. Shenk,(unknown),(unknown),Xiaofen Li,Reina Natero,Yuan Li,Marie L. Nguyen,S.S. Kerwar,Nancy Chu,(unknown),(unknown),(unknown),(unknown),Dewan Zeng,Kwan Leung,Jeff Zablocki	25
13	New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties 2003 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun,(unknown),Kevin D. Shenk,Elfatih Elzein,Yuan Li,Marie L. Nguyen,S.S. Kerwar,Dewan Zeng,Nancy Chu,(unknown),(unknown),(unknown),(unknown),(unknown),Heather Fraser,Jeffery A. Zablocki	22
14	Structure–affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor 2002 ·Bioorganic & Medicinal Chemistry Letters ·Venkata P. Palle,Elfatih Elzein,Scott A. Gothe,(unknown),Zhenhai Gao,Stephanie Meyer,Brent Blackburn,Jeff Zablocki	25
15	Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Zhenhai Gao,Zhihe Li,Stephen P. Baker,Robert D. Lasley,Stephanie Meyer,Elfatih Elzein,Venkata P. Palle,Jeff Zablocki,Brent Blackburn,Luiz Belardinelli	108
16	2-SUBSTITUTED PI SYSTEM DERIVATIVES OF ADENOSINE THAT ARE CORONARY VASODILATORS ACTING VIA THE A_2AADENOSINE RECEPTOR 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Jeff Zablocki,Venkata P. Palle,(unknown),Elfatih Elzein,(unknown),Scott A. Gothe,Zhenhai Gao,(unknown),Stefan Meyer,Luiz Belardinelli	29
17	Synthesis, Antifolate, and Antitumor Activities of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines 2001 ·Journal of Medicinal Chemistry ·Aleem Gangjee,(unknown),Elfatih Elzein,John J. McGuire,Sherry F. Queener,Roy L. Kisliuk	57
18	ChemInform Abstract: 2‐Substituted Pi System Derivatives of Adenosine That Are Coronary Vasodilators Acting via the A_2A Adenosine Receptor 2001 ·ChemInform ·Jeff Zablocki,Venkata P. Palle,(unknown),Elfatih Elzein,(unknown),Scott A. Gothe,Zhenhai Gao,(unknown),Steven De Meyer,Luiz Belardinelli	1
19	Classical and Nonclassical Antifolates as Potential Antitumor, Antipneumocystis and Antitoxoplasma Agents 1996 ·Current Pharmaceutical Design ·Aleem Gangjee,Elfatih Elzein,(unknown),Anil Vasudevan	31
20	Interference of Herbal Drinks with Urinalysis for Drugs of Abuse 1993 ·Journal of Analytical Toxicology ·Charles L. Winek,Elfatih Elzein,Wagdy W. Wahba,(unknown)	13

About Elfatih Elzein

Elfatih Elzein is a scholar working on Physiology, Organic Chemistry and Biochemistry, having authored 28 papers that have together received 849 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (14 papers), Synthesis and Biological Evaluation (9 papers) and Cardiac electrophysiology and arrhythmias (5 papers). The work is most often cited by research in Physiology (340 citations), Organic Chemistry (286 citations) and Cardiology and Cardiovascular Medicine (146 citations). Elfatih Elzein has collaborated with scholars based in United States, Belarus and United Kingdom. Frequent co-authors include Jeff Zablocki, Venkata P. Palle, Rao Kalla, Dewan Zeng, William F. Kiesman, Thao Perry, Aleem Gangjee, Xiaofen Li, Luiz Belardinelli and Zhenhai Gao. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact